Mesoblast could need another COVID trial says CEO
MELBOURNE: Losses at stem cell treatments producer Mesoblast have hit $US98.8 million ($135 ... read more
Healius eyes M&A after sales surge says CEO
MELBOURNE: Healius boss Malcolm Parmenter says the healthcare giant is seeking to make ... read more
Regis Healthcare set to reinstate final dividend
MELBOURNE: Regis Healthcare has reinstated its final dividend despite a host of issues ... read more
Australian patients use 4D Medical’s smart lung tech
MELBOURNE: Lung tracker 4DMedical is expanding the use of its respiratory imaging platform ... read more
